biotech
Bio-AnalystSupplement research
person

D-Ribose

Selected research topic

Glucose and metabolic health

The confirmed comparison studies tested several ingredients together. They cannot isolate the effect of this ingredient.

Publications for this topic
3
Human comparison publications
1
Publications needing review
2

Findings in the studies

  • %fat

    • A better result than the comparison group was reported.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      General population · Combination study · PRE to MID3 (3 weeks).
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Study comparison: Greater reduction in %fat for the combined recovery drink than carbohydrate-only control from PRE to
      Additional measurement information
      Secondary outcome
      Measurement time
      PRE to MID3 (3 weeks).

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • HbA1c · Distinct papers needing additional review: 1Direction unclear: 1
  • serum glucose · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Human studies reported between-group improvement in %fat.

combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · between-group comparison

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: Not yet rated

The 0.0 evidence score includes 3 independent human studies and 3 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, a meaningful share of null findings in the same benefit area.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 52

Papers linked to this topic 3 · distinct papers 3 · papers with a confirmed human comparison 1 · papers needing additional review 2

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • %fat: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • HbA1c: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • serum glucose: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

%fat

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum glucose

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Review 1 combination findings and 0 findings that outperformed an ingredient alone.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Cytotoxicity1 papers
The review highlights potential negative effects of D‑ribose, including increased glycation and cytotoxicity, suggesting caution in its use.Human studies · Study type not identified

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

크레아틴A double-blind RCT in 53 patients with ischemic heart disease found that a combination supplement containing D-ribose, creatine, and vitamins improved cardiac double product and exercise tolerance compared to placebo, though the authors note the surrogate measure requires further validation.